An improved cerulean fluorescent protein with enhanced brightness and reduced reversible photoswitching by Markwardt, M.L. (Michele) et al.
An Improved Cerulean Fluorescent Protein with
Enhanced Brightness and Reduced Reversible
Photoswitching
Michele L. Markwardt1, Gert-Jan Kremers2¤, Catherine A. Kraft1, Krishanu Ray3, Paula J. C. Cranfill4,
Korey A. Wilson4, Richard N. Day5, Rebekka M. Wachter6, Michael W. Davidson4, Mark A. Rizzo1*
1Department of Physiology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, 2Department of Molecular Physiology and
Biophysics, Vanderbilt University, Nashville, Tennessee, United States of America, 3Center for Fluorescence Spectroscopy and the Department of Biochemistry and
Molecular Biology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America, 4National High Magnetic Field Laboratory and Department
of Biological Science, The Florida State University, Tallahassee, Florida, United States of America, 5Department of Cellular and Integrative Physiology, Indiana University
School of Medicine, Indianapolis, Indiana, United States of America, 6Department of Chemistry and Biochemistry, Arizona State University, Tempe, Arizona United States
of America
Abstract
Cyan fluorescent proteins (CFPs), such as Cerulean, are widely used as donor fluorophores in Fo¨rster resonance energy
transfer (FRET) experiments. Nonetheless, the most widely used variants suffer from drawbacks that include low quantum
yields and unstable flurorescence. To improve the fluorescence properties of Cerulean, we used the X-ray structure to
rationally target specific amino acids for optimization by site-directed mutagenesis. Optimization of residues in strands 7
and 8 of the b-barrel improved the quantum yield of Cerulean from 0.48 to 0.60. Further optimization by incorporating the
wild-type T65S mutation in the chromophore improved the quantum yield to 0.87. This variant, mCerulean3, is 20% brighter
and shows greatly reduced fluorescence photoswitching behavior compared to the recently described mTurquoise
fluorescent protein in vitro and in living cells. The fluorescence lifetime of mCerulean3 also fits to a single exponential time
constant, making mCerulean3 a suitable choice for fluorescence lifetime microscopy experiments. Furthermore, inclusion of
mCerulean3 in a fusion protein with mVenus produced FRET ratios with less variance than mTurquoise-containing fusions in
living cells. Thus, mCerulean3 is a bright, photostable cyan fluorescent protein which possesses several characteristics that
are highly desirable for FRET experiments.
Citation: Markwardt ML, Kremers G-J, Kraft CA, Ray K, Cranfill PJC, et al. (2011) An Improved Cerulean Fluorescent Protein with Enhanced Brightness and Reduced
Reversible Photoswitching. PLoS ONE 6(3): e17896. doi:10.1371/journal.pone.0017896
Editor: Dafydd Jones, Cardiff University, United Kingdom
Received December 7, 2010; Accepted February 14, 2011; Published March 29, 2011
Copyright:  2011 Markwardt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by a National Science Foundation grant to R.M.W. (MCB-061593), and National Institutes of Health grants GM72048, which
provided support to G.J.K. (D.W. Piston, PI), DK47301 and DK47301-15S2 to R.N.D., and DK077140 and DK077140-02S1 to M.A.R. The funders had no role in study
design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The mutant CFPs described in this article are the topic of a pending patent application from the University of Maryland, Baltimore titled
"Fluorescent Proteins and Uses Thereof" (SN 61/249,712). This patent covers the mutations used to derive mCerulean2 and mCerulean2.N variants that are the
precursors to mCerulean3. Although the authors are pursuing commercial licensing and sale of their CFP reagents through companies like Clontech and Life
Technologies, this does not alter their acceptance and adherence to the PLoS ONE policy as well as National Institutes of Health (NIH) policy for reagent sharing.
All reagents described in the article are freely available upon reasonable request for the purpose of academic, non-commercial research, which will likely include
deposition of the plasmids encoding mCerulean3 in a repository such as addgene.org.
* E-mail: mrizz001@umaryland.edu
¤ Current address: Department of Cell Biology, Erasmus Medical Center, Rotterdam, The Netherlands
Introduction
A full complement of colors for genetically-encoded fluorescent
proteins has nearly been achieved. Nonetheless, many fluorescent
proteins suffer from low brightness and unstable fluorescence that
limits their utility for live cell microscopy [1]. Additional
disadvantages include properties such as a low quantum yield
(QY) [2], inefficient maturation [3], or suboptimal excitation by
existing illumination sources [4–6]. Thus, there is continued
interest in developing fluorescent proteins with properties that are
better suited for quantitative microscopy applications.
Among the most widely used fluorescent proteins are those
derived from the Aequorea victoria green fluorescent protein
(GFP) [7]. The chromophores of fluorescent proteins are formed
from three amino acid residues positioned in the interior of the
compact b-barrel structure [8]. Spontaneous main chain cycliza-
tion of residues 65 and 67 (wild-type GFP) leads to formation of a
cyclic a-enolate, that either in its hydrated or dehydrated form, is
thought to undergo oxidation to the cyclic imine form. Net
elimination of a water molecule and proton abstraction at the b
carbon of Tyr66 produces a mature chromophore containing a
five-membered heterocycle that is fully conjugated to the phenolic
group of Tyr66 [9–12].
Molecular engineering of the chromophore-forming amino acid
residues can change both the absorption and emission spectra of
the protein, producing blue, cyan and enhanced green fluorescent
variants [13]. Replacement of Tyr66 with a tryptophan residue
introduces the larger indole group into the chromophore p-system,
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and paradoxically blue-shifts the spectra by ,30 nm to produce
the widely used set of CFPs [14]. Importantly, the spectral
properties of fluorescent proteins are determined not only by the
chromophore structure alone, but can also be influenced by
interactions with the surrounding b-barrel side chains via effects
on chromophore orientation, energetics or conformation [15]. For
CFPs, the absorption spectra can be approximated by molecular
dynamics simulations [16,17] that have provided a great deal of
insight into the experimental observations that side-chain
protonation and chromophore conformations can influence both
the brightness and absorption spectra of Cerulean [18]. Nonethe-
less, absorption spectra calculations using these models currently
lack the double peak observed experimentally, indicating that a
full understanding of the photophysical phenomena underlying the
spectral properties of CFPs has not yet been achieved.
Although CFPs are generally dim in comparison to GFPs [1],
their blue-shifted fluorescence has made CFPs a popular choice for
Fo¨rster resonance energy transfer (FRET) experiments when
paired with yellow fluorescent proteins (YFPs) such as Citrine [19]
or Venus [3]. FRET is typically detected by quantifying changes in
sensitized YFP emission, either ratiometrically with CFP fluores-
cence or using a corrective algorithm. Alternatively, the quenching
effect of FRET on CFP fluorescence can be detected by
photobleaching YFP or by measuring changes to the CFP
fluorescence lifetime. Despite the convenience of the CFP color,
the most commonly used CFPs do have drawbacks that limit their
utility in FRET experiments. For example, the low QY of
commonly used CFPs [20,21] limits FRET efficiency and the
range of energy transfer [22]. Instability of CFP fluorescence can
also be problematic for time-resolved FRET experiments.
Although corrective measures have been developed to account
for photobleaching [23,24], application of these methods is
complicated by the reversibility of the fluorescence loss. This
phenomenon is known as reversible photoswitching and has been
observed for several fluorescent proteins including Cerulean [25].
Improvements to CFPs that target QY and photostability are thus
particularly important for quantitative FRET experiments.
To improve the properties of Cerulean CFP [20] fluorescence,
we optimized amino acids in the b-barrel and in the chromophore.
The resulting protein is 67% brighter than the original Cerulean
fluorescent protein and 21% brighter than the recently reported
mTurquoise fluorescent protein [26], which is a high QY CFP
derived from the alternative super-folding CFP lineage (SCFP3A)
[21]. Although brightness was improved, the absorption and
emission spectra of mCerulean3 did not change substantially
compared to previous CFPs, including the original Cerulean.
mCerulean3 also shows greatly reduced reversible photoswitching,
and performs well as a fusion protein. In addition, we show that
mCerulean3 provides quantitative advantages for FRET experi-
ments over previous CFP variants.
Results and Discussion
Optimization of Cerulean fluorescence
The crystal structure of Cerulean [18,27] reveals an extended
separation between b-strands 7 and 8 (Figure 1A, in red and green,
respectively). In general, unfolding fluorescent proteins reduces
fluorescence, and direct manipulation of the b-strands by the
addition of biosensing domains is known to modulate the
molecular brightness of fluorescent proteins [3,28,29]. Thus, we
hypothesized that optimizing the amino acids that comprise b-
strands 7 and 8 might improve the overall brightness of Cerulean.
Random mutations were introduced in pairs into the monomeric
variant of Cerulean (mCerulean) [5] using degenerate primers
(Table S1). Plasmid DNA containing mCerulean mutants were
transformed into XL10 bacteria and colony fluorescence was
examined by fluorescence microscopy. Plasmids isolated from the
brightest colonies were used to generate recombinant proteins for
characterization. Although increased colony brightness could result
from factors unrelated to protein brightness, such as cell density or
differences in protein concentration within the bacterial cells, we did
find that increased colony brightness was associated with increased
molecular brightness in purified proteins. Mutant CFPs with the
highest QYs were selected for additional rounds of optimization.
The end product from this series of optimization, mCerulean2,
contains 6 mutations (S147H/D148G/K166G/I167L/R168N/
H169C; sequence alignment in Figure S1) and is 30% brighter than
Cerulean (Table 1) while maintaining similar absorption and
emission spectra (Figure 2). Thus, optimization of residues in b-
strands 7 and 8 improved the fluorescence of Cerulean.
Although the QY of mCerulean2 is 25% greater than Cerulean,
it is quite far from the theoretical maximum. Optimization of
Thr203 (Figure 1B), which is proximal to the chromophore, is
known to improve the fluorescence properties of some Aequorea-
derived GFP variants [30]. To assess whether optimization of
Thr203 can enhance the fluorescence properties of mCerulean2,
we performed random mutagenesis on this position using
degenerate PCR, and screened mutant-containing bacterial
colonies for brightness. The brightest protein identified contained
the T203I mutation and was named mCerulean2.N. This variant
has a ,9 nm red shift in its fluorescence spectra (Figure 2) which
may provide advantages for certain applications since the peak
absorption is more closely aligned with 440 nm and 458 nm laser
sources compared to mCerulean2. Furthermore, the ,9 nm shift
in the emission spectrum is large enough to permit resolution from
the Cerulean spectrum by linear unmixing [31], thus adding
another potential color for spectral imaging applications. None-
theless, the gains in QY observed from the mCerulean2 mutations
were negated, even though the molar extinction coefficient was
improved. Therefore, mCerulean2.N is a CFP of similar
brightness to Cerulean with spectral properties that are more
closely aligned with existing laser excitation sources commonly
used for fluorescence microscopy.
To further improve mCerulean2 fluorescence, we examined the
effect of reverting position Thr65 in the chromophore to the wild-
type serine residue. Early cyan mutants containing the Ser65 had
much higher QYs (W2; QY=0.72) [14] than the widely used
S65T-containing ECFP (originally W1B; QY=0.4) [30]. Further-
more, it has recently been shown that the wild-type T65S
substitution can improve the QY of blue fluorescent proteins
[2,32]. Incorporation of T65S into mCerulean2 (mCerulean3)
successfully improved the QY of mCerulean2 by 45% and the
overall brightness by 25% (Table 1) without changing the
absorption or fluorescence emission spectra (Figure 2). The acid
stability of mCerulean3 (pKa=3.2) was also better than
mCerulean2 (pKa=4.8), mCerulean2.N (pKa= 4.5) and mCer-
ulean (pKa=4.7). In contrast, incorporation of T65S into
mCerulean2.N did not improve overall fluorescence, and slightly
reduced both the QY and the extinction coefficient. Thus,
incorporation of the wild-type Ser65 into mCerulean2 greatly
improved fluorescence through a mechanism that is incompatible
with the T203I mutation, the precise nature of which is unknown.
Comparison of recombinant mCerulean3 with previous
CFPs
We compared the fluorescence properties of the brightest CFP
we developed, mCerulean3, with another recently developed CFP
that also contains the T65S mutation, mTurquoise [26]. Overall,
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we found mCerulean3 to be approximately 20% brighter than
mTurquoise while the absorption and emission peaks are similar
(Table 1). Like mTurquoise, the fluorescence lifetime of mCer-
ulean3 determined by time-correlated single photon counting
(TCSPC) spectroscopy fits well to a single exponential component.
The maturation times of mTurquoise and mCerulean3 are also
very similar (Table 1). Thus, the steady-state spectral qualities of
mCerulean3 are roughly equivalent to mTurquoise, with mCer-
ulean3 being the brighter of the two.
By convention, we measured the fluorescence decay times for
beads labeled with CFPs under continuous illumination. mCer-
ulean2 and mTurquoise behaved similarly to mCerulean;
however, mCerulean3 was resistant to fluorescence decay under
these conditions. We observed an ,18-fold longer decay half time
for mCerulean3 than mTurquoise. Nonetheless, measurement of
fluorescence decay times under continuous illumination has
generally not provided reproducible results between laboratories
[20,21,33], and therefore may not be the most useful predictor of
performance. In addition, measurement of the rate of decay under
continuous illumination does not take into account that some of
the fluorescence loss may be reversible [25] and not indicative of a
true photobleach. To distinguish between reversible photoswitch-
ing and irreversible bleaching, we imaged beads labeled with
recombinant fluorescent proteins at 1 min intervals to establish
baseline fluorescence using a low-power illumination intensity that
we have successfully used for observation of living cells expressing
CFPs. During the imaging protocol we illuminated continuously
for a 1 min period to observe the extent of fluorescence decrease,
and resumed imaging at 1 min intervals to quantify the extent of
reversible photoswitching (Figure 3A, B). For Cerulean, and to a
lesser extent, mTurquoise, the reduction of fluorescence induced
by the 1 min illumination period was highly variable (for Cerulean,
Figure 1. Optimization of Cerulean. A site-directed mutagenesis strategy was employed to optimize Cerulean fluorescence. (A) Residues on b-
strand 7 (S147, D148; red), b-strand 8 (L166, I167, R168, H169; green) in the Cerulean X-ray structure (2wso.pdb [27]) were targeted for optimization
by site-directed mutagenesis. The chromophore is colored blue. (B) T203 (orange) was targeted for optimization due to its proximity to the
chromophore. T65 (green) was also mutated.
doi:10.1371/journal.pone.0017896.g001
Table 1. Fluorescence properties of CFPs.
Protein
Excitation
maximum
[nm]
Emission
Maximum
[nm] epeak (M
21cm21) QY Brightnessa
Fluorescence
Decay t0.5
b (s) kfold
c (1022 s21) td (ns)(x2 e)
Cerulean 434 475 43,000 0.48 21 58 0.54 3.17 (0.03 (2.70)
mCerulean2 432 474 47,000 0.60 28 25 1.62 3.04 (0.03 (4.00)
mCerulean2.N 440 484 49,000 0.48 24 36 1.79 2.63 (0.03 (3.41)
mCerulean2.N(T65S) 439 481 43,000 0.46 20 – – –
mCerulean3 433 475 40,000 0.87 35 1100 1.90 4.10 (0.02 (1.05)
mTurquoise 434 474 34,000 0.84 29 61 1.93 4.04 (0.03 (1.04)
aBrightness was calculated as the product of epeak and QY.
bt0.5 value of a single exponential fit for fluorescence decay under constant fluorescence illumination at 300 mW/cm
2.
cRefolding rate from denatured protein was determined using the method from reference [3].
dThe fluorescence lifetime time constant (6 SD) was obtained from a single-component fit of TCSPC spectroscopy data.
eValue reports the goodness of fit for the lifetime data.
doi:10.1371/journal.pone.0017896.t001
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217.668.6% reduction; all values are mean 6 standard deviation
(SD)) (Figure 3C). In addition, reversible fluorescence photoswitching
was observable for both mTurquoise and Cerulean, and accounted
for roughly half of the fluorescence decrease observed for
mTurquoise beads over the 1 min continuous illumination period.
In contrast, mCerulean3 was refractory to fluorescence reduction
(1%60.4, n=15). Interestingly, we did not observe reversible
photoswitching in beads labeled with mCerulean2.N, although the
extent of irreversible photobleaching was extensive (Figure 3C).
Taken together, we find that recombinant mCerulean3 is exception-
ally photostable compared to other Aequorea-derived CFPs.
Characterization of mCerulean3 expressed in cells
To test the suitability of mCerulean3 as a fusion protein, we fused it
to a variety of different localization partners, including actin, myosin,
and organelle-localized domains (Figure 4). Bright, successfully
localized fusions were accomplished using both the N-terminus and
C-terminus of mCerulean3, including those that require monomeric
character, such as a-tubulin, intermediate filaments, connexin 43,
histone H2B, and b-actin. Thus, mCerulean3 is suitable as a fusion
partner for a broad range of molecular targets.
Although the photostability of existing CFPs is sufficient to
enable their widespread use in a great number of applications,
reversible photoswitching in living cells has the potential to
introduce an undesirable source of error in quantitative applica-
tions. To examine the fluorescence photoswitching behavior of
CFPs in COS-7 cells, we bleached cells to 50% of their initial
fluorescence by continuous illumination of the full field of view
over several minutes. Reversible photoswitching was then
quantified as the percent increase in fluorescence at 15 min
compared to the post-bleach fluorescence intensity (Figure 5). In
COS-7 cells, mTurquoise fluorescence recovered to a smaller
extent than Cerulean, although the amount of reversible
photoswitching was statistically significant (P,0.001, t-test,
comparison to 0, n= 20). In contrast, we observed very little
reversible photoswitching in cells expressing mCerulean3
(2.5%66.2, n= 20), and the small amount observed was not
statistically significant (t-test, comparison to 0, P.0.05). Thus,
mCerulean3 performs well as a fusion protein and displays very
little fluorescence photoswitching when expressed in living cells.
Performance of mCerulean3 in FRET experiments
The CFP:YFP pairing is a widely used combination for FRET
experiments in living cells. Consistent with dependence of FRET
on the donor QY [22], the calculated Fo¨rster distance where half
maximal energy transfer occurs (R0) was improved for pairing
mCerulean3 with the mVenus YFP [3] compared to the
monomeric mCerulean alone (Table 2), whereas the Fo¨rster
distances calculated for mTurquoise and mCerulean3 were very
similar. These trends were reflected experimentally in HeLa cells
expressing a fused CFP:YFP dimer containing mCerulean,
mTurquoise, or mCerulean3 coupled to mVenus. FRET efficien-
cies were determined in single cell preparations using acceptor
photobleaching (Table 2). FRET efficiencies for mTurquoise and
mCerulean3-containing fusions were greater than the mCerulean
fusion (P,0.001, n= 15, ANOVA, Tukey multiple comparison for
mTurquoise:mCerulean, and mCerulean3:mTurquoise); however,
FRET efficiencies obtained for mCerulean3 and mTurquoise
fusions were not significantly different (P.0.05). These findings
are consistent with the calculated R0.
Accurate FRET efficiencies can be obtained by measuring
changes to the donor fluorescence lifetime in the presence of the
acceptor [34], and FRET-induced changes to CFP lifetimes can be
observed by fluorescence lifetime microscopy (FLIM) [5,35]. We
quantified the FRET efficiencies of our fusion constructs using
frequency domain FLIM. Fluorescence lifetimes obtained by FLIM
(Figure S2) for mCerulean (t=3.0060.06, n= 10), mCerulean3
(t=3.9760.04, n= 10), and mTurquoise (t=4.0060.05, n= 10)
were in fairly good agreement with values obtained for recombinant
proteins using time correlated single photon counting (TCSPC)
spectroscopy (Table 1). There was more divergence with the
frequency-domain FLIM and TCSPC values for Cerulean. This
finding is in agreement with previous reports and the divergence is
believed to result from the complexity of the Cerulean lifetime
[21,26]. FRET efficiencies obtained with FLIM also agreed with
results obtained from donor dequenching (Table 2), with mCer-
ulean3 and mTurquoise-containing fusions showing significantly
more FRET than Cerulean (P,0.001, n= 10, ANOVA, Tukey
multiple comparison for mTurquoise:mCerulean, and mCeru-
lean3:mTurquoise). As we had observed with donor dequenching,
FRET efficiencies for mCerulean3 and mTurquoise containing
fusions were not significantly different from each other (P.0.05,
n= 10, ANOVA, Tukey multiple comparison test). Taken together
with the acceptor photobleaching data, the recently developed high
QY CFPs show measurable improvement over Cerulean in the
efficiency of CFP:YFP FRET.
Many CFP:YFP FRET experiments utilize the ratio of the
donor and acceptor fluorescence to detect changes induced by
biosensing of cellular phenomena [36]; however, the instability
and decay of CFP fluorescence over time could in theory affect the
absolute FRET ratio if the decay in CFP fluorescence is shorter
than the image capture time. To examine this in the context of
FRET-ratio imaging, we labeled beads with recombinantly-
generated CFP:YFP pairs, and examined the FRET ratio of
beads over a broad range of image capture times using wide-field
microscopy (Figure 6A). FRET ratios from fusions containing
mCerulean or mTurquoise and mVenus were 10–20% less at long
illumination times (,1 s) compared with short ones (,1 ms)
(Figure 6A). In contrast, FRET ratio measurements performed
Figure 2. Spectral properties of new CFPs. Absorption (dashed
lines) and emission spectra (solid lines) are shown for Cerulean (black),
mCerulean2 (green), mCerulean2.N (red), and mCerulean3 (blue).
Spectra were normalized to the peak absorption or emission values.
doi:10.1371/journal.pone.0017896.g002
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using mCerulean3 as a donor varied less than 2.5% as exposure
time was varied over 4 orders of magnitude. To look at the impact
of mCerulean3 photostability on FRET ratios observed in living
cells, we expressed the same FRET fusion proteins containing
mVenus that we used for the bead preparations in HEK cells
(Figure 6B). Using mCerulean as the FRET donor, we observed
FRET ratios ranging from 1 to 2.6 (Figure 6B), with a large SD of
60.57 (n= 50). FRET ratios obtained for mTurquoise fusions
were less variable (60.37, n = 50), but the SD was still 2.5-fold
greater than the results obtained with mCerulean3 fusions (60.15,
n = 50). Given that the improvement observed using mCerulean3
over mTurquoise is quite large compared to a small brightness
advantage, it is likely that reduced photoswitching is the major
component of the reduced variability. Thus, utilization of
mCerulean3 as donor protein in FRET experiments reduces
variability in ratio measurements.
Conclusions
Here we report development of a brighter, more photostable
Cerulean CFP with very desirable characteristics for quantitative
fluorescence microscopy applications. mCerulean3 has very high QY
and a single exponential fluorescence lifetime, making it a very useful
donor fluorophore for FRET experiments. The reduced photo-
switching behavior is also an important advantage for quantitative
applications such as FRET and fluorescence recovery after photo-
bleaching. Compared to the other high QY CFP, mTurquoise,
FRET with mCerulean3 is similarly efficient, but can be quantified
with greater precision. FRET ratios obtained with mCerulean3
display less variance in test preparations and in living cells. Reduced
variability in FRET measurements is particularly beneficial for
FRET-based biosensors, where the dynamic range is frequently 20%
or less [37–39]. Furthermore, once mCerulean3 is bleached in cells,
the fluorescence does not significantly change through reversible
photoswitching. Not only will this simplify interpretation for
fluorescence photobleaching experiments, but it also will enhance
the utility of corrective photobleaching algorithms [24,40]. This is of
particular importance considering we find that the fraction of
fluorescence loss that is reversible can vary greatly, even in highly
controlled sample bead preparations. Thus, mCerulean3 possesses
special advantages for quantitative live-cell imaging applications.
Figure 3. Photostability of recombinant CFPs. Agarose beads labeled with CFPs as indicated were imaged at 60 s intervals under low power
illumination (45 mW/cm2). At 5 min, the beads were continuously illuminated for 60 s (red bar). (A) Representative images from the experimental data
set are shown in pseudocolor to represent bead intensity. The scale bar indicates 10 mm. (B) Bead fluorescence was normalized to prebleached
intensity and plotted versus time. Bars indicate SD (n.15 for all samples). (C) The reversible (white) and irreversible (blue) bleached fractions were
quantified over the 20 min recovery period.
doi:10.1371/journal.pone.0017896.g003
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Figure 4. Fluorescence imaging of mCerulean3 fusion vectors. Images were recorded in widefield or laser scanning confocal fluorescence
microscopy. (A–M) Fusions to the N-terminus of mCerulean3; for each fusion protein the linker amino acid (aa) length is indicated after the name of
the targeted organelle or fusion protein. The origin of the targeting cDNA is indicated in parenthesis. (A) mCerulean3-Cx43-7 (rat); (B) mCerulean3-
EB3-7 (human microtubule-associated protein; RP/EB family); (C) mCerulean3-Golgi-7 (N-terminal 81 aa of human b-1,4-galactosyltransferase); (D)
mCerulean3-a-actinin (human); (E) mCerulean3-PMP-10 (human peroxisomal membrane protein 2); (F) mCerulean3-c-src-7 (chicken c-src tyrosine
kinase); (G) mCerulean3-mitochondria-7 (human cytochrome C oxidase subunit VIII); (H) mCerulean3-zyxin-7 (human); (I) mCerulean3-vimentin-7
(human); (J) mCerulean3-lifeact-7 (N-terminal 17 aa from S. cerevisiae Abp 140); (K) mCerulean3-VE-Cadherin-10 (human vascular epithelial cadherin);
A Bright, Photostable Cyan Fluorescent Protein
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Materials and Methods
Cloning and Gene Construction
Synthetic DNA oligonucleotides for cloning and mutagenesis
were purchased from Integrated DNA Technologies (Coralville,
IA). PCR products and products of restriction digests were purified
by gel electrophoresis and extraction using the QIAquick gel
extraction kit (Qiagen, Valencia, CA). Plasmid DNA was purified
from overnight cultures using the QIAprep Spin Miniprep kit
(Qiagen). Restriction endonucleases were purchased from Invitro-
gen (Carlsbad, CA) or New England Biolabs (Ipswich, MA).
Sequencing was used to confirm the complete cDNA sequences for
all fluorescent protein variants and fusion constructs (Florida State
University Bioanalytical and Molecular Cloning DNA Sequencing
Laboratory, the University of Maryland School of Medicine DNA
sequencing facility, GENEWIZ Maryland Laboratory, or the
DNA sequencing core facility at the Indiana University School of
Medicine). Preparation of DNA for mammalian transfection and
transformation was performed using DNA prep kits from Qiagen
(QIAprep Spin Miniprep Kit, HiSpeed Plasmid Midi, Plasmid
Midi, or Maxi kit).
Mutagenesis and screening
Mutants were introduced into H6mCerulean [5] contained in
the pQE9-N1 bacterial expression plasmid [20] by PCR using the
Quikchange mutagenesis kit (Agilent Technologies, Wilmington,
DE) together with the primers listed in Table S1. Mutant plasmids
were transformed into XL10-Gold Ultracompetent cells (Agilent
Technologies) according to the manufacturer’s instructions. Even
though this strain contains the lacIq mutation, repression of protein
production was sufficiently leaky to enable observation of CFP
fluorescence. Transformed cells were plated on LB agar plates
containing 100 mg/ml ampicillin, and incubated overnight at
37uC. For screening, 4–15 colonies were transferred to a 25 mm
filter (Nucleopore Track-Etch Membrane, GE Healthcare,
Carlsbad, CA). The filter was then placed colony side up on the
bottom of a sterile 60 mm cell culture dish and screened for
brightness (filter set ET436/20X exciter, T455LP beamsplitter,
ET480-40m-2p (Chroma Technology Corp., Bellows Falls, VT)
using an inverted Zeiss Axiovert 200M with a 16, 0.025 NA
objective lens. Dishes were heated to 50uC to improve contrast.
Typically, ,100 colonies were initially screened for brightness and
the 5 brightest colonies were selected for additional screening.
Colonies were grown in culture for 1 h at 37uC, and streaked on
LB agar plates containing 100 mg/ml ampicillin. The following
day, single colonies were transferred to a single filter for
comparison, and the brightest colony was selected and cultured
in 5 ml LB (100 mg/ml ampicillin) for DNA miniprep (QIAprep
spin, Qiagen).
Purification of recombinant proteins
The Qiagen T5 expression system was used to generate proteins
from modified pQE9 vectors described elsewhere [5,20]. Mutant
CFPs selected for additional characterization were transformed
into M15(pRep4) bacteria for protein production. Induction with
isopropyl b-D-1-thiogalactopyranoside, harvesting and lysis are
described elsewhere [5]. Recombinant proteins were purified using
Ni+2 loaded 1 ml HiTrap Chelating HP columns (GE Healthcare)
according to the manufacturer’s instructions. Protein concentra-
tion was determined using the Advanced Protein Reagent (Sigma-
Aldrich, St. Louis, MO), and gel electrophoresis as described
previously [5].
Recombinant protein vectors
H6mTurquoise was prepared by site-directed mutagenesis of
H6SCFP3A using the T65S primers listed in Table S1.
Recombinant H6mVenus:mCerulean3 contains a 10 aa linker,
and was derived using the cloning strategy for the short linker
FRET pairs as previously described [5]. Production of H6Ceru-
lean and H6mCerulean has also been described [5,20].
Mammalian expression vectors
For mammalian expression, novel fluorescent protein constructs
were subcloned from the pQE9 vector into the pEGFP-C1 using
NheI and HindIII restriction sites. N3 and N1 constructs were
generated by PCR using previously described methods [5]. To
generate subcellular localization fusion vectors used for experi-
(L) mCerulean3-fascin-10 (human fascin); (M) mCerulean3-lysosomes-20 (human lysosomal membrane glycoprotein 1; LAMP-1). (N–Y) Fusions to the
C-terminus of mCerulean3. (N) mCerulean3-lamin B1-10 (human); (O) mCerulean-MAP4-10 (mouse microtubule associated protein 4, nucleotides
1918–3135); (P) mCerulean3-lc-myosin-10 (mouse myosin light chain 9); (Q) mCerulean3-CDC42-10 (human cell division cycle 42); (R) mCerulean3-a-
tubulin-6 (human); (S) mCerulean3-PCNA-19 (human proliferating cell nuclear antigen); (T) mCerulean3-profilin-10 (mouse profilin); (U) mCerulean3-
clathrin light chain-15 (human); (V) mCerulean3-CAF1-10 (mouse chromatin assembly factor 1); (W) mCerulean3-fibrillarin-7 (human fibrillarin); (X)
mCerulean3-b-actin-7 (human); (Y) mCerulean-Rab5a-7 (human GTPase Rab5a). (Z1–Z5) mCerulean3-H2B-6 (human) illustrating the various phases of
mitosis. (Z1) interphase; (Z2) prophase; (Z3) metaphase; (Z4) anaphase; (Z5) early telophase. Scale bars indicate 10 mm.
doi:10.1371/journal.pone.0017896.g004
Figure 5. Fluorescence photoswitching behavior of CFPs in
living cells. COS7 cells expressing the indicated CFP were examined by
widefield microscopy. Cells were bleached to 50% of their initial
fluorescence by continuous, high intensity illumination of the full field
of view. Recovery of cellular fluorescence was examined 15 min
following the bleaching period. Data indicates the mean % recovery
of bleached fluorescence after 15 min (n = 20, two-tailed t-test,
difference from 0, *** indicates P,0.001, mCerulean3 recovery was
not statistically significant (ns) under the same test, P=0.09, n = 20).
doi:10.1371/journal.pone.0017896.g005
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ments in Figure 4, the appropriate cloning vector and an
mEmerald fusion vector were digested, either sequentially or
doubly, with the appropriate enzymes and ligated together after
gel purification. Thus, to prepare mCerulean3 N-terminal fusions,
the following digests were performed: human non-muscle a-
actinin, EcoRI and NotI (vector source, Tom Keller, FSU); human
cytochrome C oxidase subunit VIII, BamHI and NotI (mitochon-
dria, Clontech); human zyxin, BamHI and NotI (Clare Water-
man-Storer, NIH); rat a-1 connexin-43, EcoRI and BamHI
(Matthias Falk, Lehigh University); human H2B, BamHI and NotI
(George Patterson, NIH); N-terminal 81 aa of human b-1,4-
galactosyltransferase, BamHI and NotI (Golgi, Clontech); human
microtubule-associated protein EB3, BamHI and NotI (Lynne
Cassimeris, Lehigh University); human vimentin, BamHI and
NotI (Robert Goldman, Northwestern University); human perox-
isomal membrane protein 2, NotI and AgeI (peroxisomes;
OriGene); c-src, BamHI and NotI (chicken c-src tyrosine kinase,
Marilyn Resh, Sloan-Kettering Institute); lifeact, BamHI and NotI
(N-terminal 17 aa from S. cerevisiae Abp 140, IDT); VE-cadherin,
BamHI and NotI (human vascular epithelial cadherin, Andreea
Trache, Texas A&M); fascin, BamHI and NotI (human fascin,
OriGene). To prepare mCerulean3 C-terminal fusions, the
following digests were performed: human b-actin, NheI and BglII
(Clontech); human a-tubulin, NheI and BglII (Clontech); human
light chain clathrin, NheI and BglII (George Patterson, NIH);
human lamin B1, NheI and BglII (George Patterson, NIH); mouse
MAP4, NheI and BglII (mouse microtubule associated protein 4,
nucleotides 1918–3135, Richard Cyr, Penn State University);
mouse light chain 9 myosin, NheI and BglII (Patricia Wadsworth,
University of Massachusetts); human CDC-42, NheI and BglII
(OriGene); PCNA, AgeI and BspEI (David Gilbert, FSU); mouse
CAF-1, NheI and BglII (Akash Gunjan, FSU); human fibrillarin,
AgeI and BspEI (Dimitry Chudakov, Russian Academy of
Sciences); human GTPase Rab5a, NheI and BglII (Vicky Allen,
University of Manchester).
For FRET efficiency and lifetime microscopy experiments, the
plasmid encoding the mCerulean:mVenus fusion was provided by
Dr. Steven Vogel (NIH) [41], and was used to generate the
mCerulean3:mVenus and mTurquoise:mVenus fusion proteins
described in Table 2 by substituting the coding sequence for
mCerulean with the cDNA for mCerulean3. The mVenus:mCer-
ulean construct used in Figure 6B is the short linker sensor
previously described [20]. mVenus:mCerulean3 and mVenus:m-
Turquoise fusions were constructed using an identical strategy.
Spectroscopic characterization of recombinant proteins
Absorption spectra were collected using a UV-mini absorbance
spectrometer (Shimadzu, Columbia, MD), and emission spectra
were collected on QM-3 fluorometer (Photon Technology
International, Birmingham, NJ). Molar extinction coefficients
were calculated as previously described [5]. Fo¨rster distances were
calculated as previously described [5] using QY, extinction
coefficients, and overlap integrals generated from freshly prepared
mCerulean, mTurquoise, mCerulean3, and mVenus proteins. The
pKa for fluorescence was measured and calculated also as
described [20]. Renaturation assays were performed by a
previously described method [3]. For the initial comparative QY
measurements, optical densities at 425 nm were set to 0.05, and
total fluorescence was measured from 430 to 600 nm (425 nm
excitation). Polarizers were set at magic angle conditions to
account for polarization bias. Final data normalization was
performed using a fluorescein solution as a reference standard
(QY=0.95 in 0.1 M NaOH [42]; 425 nm excitation, 430–
650 nm emitted light collection), using identical instrument
parameters for CFP specimens, including the expanded emission
range. Fluorescence lifetimes were obtained by TCSPC spectros-
copy using a FluoTime 100 (PicoQuant Photonics, Westfield,
MA). Data was acquired under magic angle conditions using
440 nm excitation, and collection with a 475 nm long pass filter.
Time constants were obtained from a single component fit using
FluoFit software (PicoQuant).
Experiments using fluorescent-protein labeled beads
For bleaching measurements, HiTrap beads were labeled with
fluorescent protein as previously described [43,44] and mounted in
Prolong Gold (Invitrogen). Imaging was performed using an
AxioObserver microscope platform (Carl Zeiss MicroImaging,
Thornwood, NY). High-speed imaging of fluorescence decay
under constant 455 nm light-emitting diode illumination was
performed using a water-cooled C9100-13 EM-CCD (Hama-
matsu, Bridgewater, NJ) to capture 300 images. Illumination
power was measured at the objective lens prior to experimentation
using a Newport 1918C power meter. Decay in fluorescence was
quantified and fit to a single exponential decay using Prism
software (Graphpad Software, La Jolla, CA). The t0.5 for the curve
fit was reported. Photoswitching measurements were performed
using a water-cooled Hamamatsu C10600 Orca-R2 CCD, under
455 nm light-emitting diode illumination. Cyan fluorescence for
single color experiments was captured using a High Efficiency
CFP filter set (47HE, Zeiss). FRET images were obtained under
cyan illumination (455 LED, BP 436/25 filter) and passed through
a T455lp dichroic beamsplitter (Chroma). Cyan and yellow
fluorescence were simultaneously collected in a single image using
an Optical Insights Dual-view system (Photometrics Headquarters,
Tucson, AZ) with a CFP/YFP beamsplitter. Images were
processed using ImageJ software (http://rsbweb.nih.gov/ij/).
Cell culture
For imaging experiments, cells were seeded on No 1.5 glass
bottom dishes (Mat-Tek Corp., Ashland, MA) prior to transfec-
tion. Prior to seeding, COS7 cells and HEK293 cells were cultured
in DMEM containing 10% fetal bovine serum (Thermo Fisher
Scientific Inc., Waltham, MA). Transfections were performed
using FuGENE 6 (Roche Applied Science, Indianapolis, IN), and
imaging was performed in phenol-red free Opti-MEM (Invitro-
gen). HeLa epithelial (CCL-2, ATCC, Manassas, VA) and Grey
Table 2. FRET efficiencies of CFP:mVenus pairs.
Protein mVenus R0 (nm) EFRET CFP:YFP dequenching EFRET CFP:YFP (FLIM)
mCerulean 5.19 0.2460.04 0.2560.02
mTurquoise 5.70 0.3060.05 0.3060.03
mCerulean3 5.71 0.3360.05 0.3060.01
doi:10.1371/journal.pone.0017896.t002
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fox lung fibroblast (CCL-168, ATCC) cells were grown in a 50:50
mixture of DMEM and Ham’s F12 with 12.5% Cosmic calf serum
(Thermo Fisher) and transfected with Effectene (Qiagen). For live
cell experiments, temperature was maintained at 37uC using a
Zeiss incubation system, or a Delta-T culture chamber (Bioptechs,
Butler, PA) under a humidified atmosphere of 5% CO2 in air.
Mouse pituitary GHFT1 cells [45] for FLIM experiments (Table 2,
Figure S2) were maintained as monolayer cultures in DMEM
containing 10% newborn calf serum. Plasmid DNA was
introduced by electroporation as described earlier [6]. The
amount of DNA was kept constant for each electroporation using
empty vector DNA. Cells were then transferred to Nunc Lab-
TekII chambered coverglass (Thermo Fisher), and maintained in
an incubator overnight before imaging. The coverglass with
attached cells was rinsed, and the chambers filled with CO2-
independent medium and placed on the microscope stage.
Live cell imaging experiments
Imaging experiments in Figure 4 were performed with a Nikon
TE-2000 inverted microscope equipped with QuantaMaxTM
filters (Omega Optical, Brattleboro, VT) and a Cascade II camera
(Roper Scientific, Trenton, NJ), or an IX71 microscope (Olympus
America, Center Valley, PA) equipped with BrightLineTM filters
(Semrock, Rochester, NY) and a Hamamatsu ImagEMTM camera.
Laser scanning confocal microscopy was conducted on a C1Si
(Nikon) and an Olympus FV1000, both equipped with argon-ion
457 nm and 405-nm diode lasers and proprietary filter sets.
Spinning disk confocal microscopy was performed on an Olympus
DSU-IX81 equipped with a Lumen 200 illuminator (Prior
Scientific, Rockland, MA), a Hamamatsu 9100-12 EMCCD
camera, Semrock filters, and 10-position filter wheels driven by
a Lambda 10-3 controller (Sutter Instrument Company, Novato,
CA). In some cases, cell cultures expressing CFP fusions were fixed
before imaging in 2% paraformaldehyde (Electron Microscopy
Sciences, Hatfield, PA 19440) and washed several times in PBS
containing 0.05 M glycine before mounting with a polyvinyl
alcohol-based medium. Morphological features in all fusion
constructs were confirmed by imaging fixed cell preparations on
coverslips using a Nikon 80i upright microscope and Omega
ECFP filter set (XF144-2) coupled to a Hamamatsu Orca ER or a
Photometrics CoolSNAPTM HQ2 camera.
Imaging experiments on COS7 cells in Figure 5 were performed
using a 406, 1.3 NA Plan-NeoFluar oil objective (Zeiss), and
illuminated with a 455 nm light emitting diode illuminator filtered
through a high efficiency CFP filter set (436/20 exciter, T455LP
beamsplitter, 480/40 emitter; Zeiss) and collected with a water-
cooled Hamamatsu C9100-13 EM CCD. Illumination intensity
and collection speeds were held constant across samples.
Acceptor photobleaching measurements were performed using
confocal microscopy. Data was collected 25 frames post bleaching
to minimize the impact of mVenus photoconversion, (photo-
converted mVenus was 0.1760.09 at frame 1, –0.0160.06 at
frame 25, n = 11). FRET Imaging experiments on HEK293 cells
in Figure 6 were performed using a 406, 0.95 NA Plan-
ApoChromat objective (Zeiss) with CFP excitation and FRET
image collection as described above for the bead calibration.
Fluorescence lifetime measurements were made using the
phasor FLIM method recently described [46–48]. Images were
collected using an Olympus IX71 epi-fluorescent microscope
equipped with a U Plan S-APO 6061.2 NA water objective lens.
The microscope was coupled to the FastFLIM frequency domain
system (ISS, Champaign, IL) and uses a 0.5 mW 448 nm diode
laser modulated at a fundamental frequency of 20 MHz for
excitation of mCerulean. The lifetime images were acquired using
a 480/40 nm emission filter, and a typical data acquisition time of
,20 s resulted in photon counts sufficient for high confidence
determination of fluorescence lifetimes. Phasor plots (Figure S2)
show the entire distribution of the mCerulean and mCerulean3
fluorescence lifetimes in the image. The phasor transformation
does not assume any fitting model for fluorescence lifetime decays,
but rather expresses the overall decay in each pixel in terms of the
polar coordinates on a universal semi-circle [49]. Once the
lifetimes of the unquenched donors were determined, the FRET
Figure 6. Improved FRET ratio imaging with mCerulean3. (A) To
test the dependence of measured FRET ratios on illumination time,
agarose beads were labeled with equivalent concentrations of the
indicated CFP:mVenus fusion protein. Beads were imaged consecutively
using constant illumination intensity (455 nm LED, 600 mW/cm2), but a
varied illumination period. Cyan and yellow fluorescence were captured
simultaneously using an Optical Insights Dual-View containing standard
CFP/YFP filter sets. FRET ratios were normalized to the peak FRET ratio.
Points indicate the mean and error bars indicate SEM (n= 10). (B) HEK293
cells were transfected with the indicated fusion, and observed by
fluorescence microscopy. The yellow/cyan FRET ratio of individual cells is
shown (n= 50). Bar indicates the mean, and error bars indicate SD.
doi:10.1371/journal.pone.0017896.g006
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efficiency (EFRET) was calculated by the equation:
EFRET~1{
tDA
tD
where tD is the lifetime of the donor in the absence of the acceptor,
and tDA is the lifetime of the donor in the presence of the acceptor.
Statistical Analysis
The indicated statistical tests were performed using Prism
software.
Supporting Information
Figure S1 Amino acid sequence alignment of CFPs. An
alignment of the amino acid sequences for CFPs created during
optimization is shown with the original mCerulean sequence and
also the sequence of mTurquoise. Amino acid substitutions are
highlighted in red. By convention, the amino acid are referred to
by their position in WT Aequorea GFP, which excludes the Val
insertion at position 2. Thus, Thr65 is actually is the sixty-sixth
amino acid in the mCerulean sequence.
(TIF)
Figure S2 Fluorescence lifetime microscopy of mCer-
ulean3. Fluorescence lifetime images of mouse pituitary GHFT1
cells expressing mCerulean (left panel), mCerulean3 (right panel).
Images were obtained using the frequency domain method. The
bottom panels show polar plot analyses of the lifetime distributions
for each image using the first harmonic (20 MHz), calculated by
the method of Redford and Clegg [49]. The average lifetime was
determined for each region of interest (red squares) and the scale
bars indicate 10 mm.
(TIF)
Table S1 Characteristics of intermediary mCerulean
variants and the primers used in their development.
(DOC)
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